SI-BONE, Inc. (SIBN) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $15.39 (+1.79%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 17, 2025 | William Plovanic | Canaccord Genuity | $27.00 | +75.4% |
| Dec 16, 2025 | David Saxon | Needham | $27.00 | +75.4% |
| Oct 15, 2025 | Richard Newitter | Truist Financial | $20.00 | +30.0% |
| Aug 11, 2025 | Ross Osborn | Cantor Fitzgerald | $25.00 | +62.4% |
| Aug 6, 2024 | Samuel Brodovsky | Truist Financial | $18.00 | +17.0% |
| Aug 6, 2024 | David Saxon | Needham | $19.00 | +23.5% |
| Mar 28, 2024 | Matt O'Brien | Piper Sandler | $25.00 | +62.4% |
| Jul 12, 2023 | David Saxon | Needham | $32.00 | +107.9% |
| May 16, 2022 | Drew Ranieri | Morgan Stanley | $22.00 | +42.9% |
Top Analysts Covering SIBN
SIBN vs Sector & Market
| Metric | SIBN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 7 | 8 | 19 |
| Target Upside | +69.2% | +11475.0% | +17.1% |
| P/E Ratio | -28.44 | 4.05 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $55M | $56M | $56M | 5 |
| 2026-09-30 | $55M | $56M | $56M | 2 |
| 2026-12-31 | $66M | $67M | $68M | 2 |
| 2027-03-31 | $61M | $62M | $62M | 2 |
| 2027-06-30 | $64M | $65M | $66M | 2 |
| 2027-09-30 | $63M | $64M | $65M | 2 |
| 2027-12-31 | $73M | $74M | $75M | 2 |
| 2028-12-31 | $306M | $306M | $306M | 1 |
| 2029-12-31 | $349M | $350M | $352M | 1 |
| 2030-12-31 | $398M | $400M | $402M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.16 | $-0.16 | $-0.16 | 4 |
| 2026-09-30 | $-0.12 | $-0.12 | $-0.12 | 1 |
| 2026-12-31 | $-0.04 | $-0.04 | $-0.04 | 2 |
| 2027-03-31 | $-0.14 | $-0.14 | $-0.13 | 2 |
| 2027-06-30 | $-0.11 | $-0.10 | $-0.10 | 1 |
| 2027-09-30 | $-0.10 | $-0.10 | $-0.10 | 1 |
| 2027-12-31 | $-0.05 | $-0.05 | $-0.05 | 2 |
| 2028-12-31 | $-0.27 | $-0.26 | $-0.25 | 2 |
| 2029-12-31 | $0.05 | $0.05 | $0.05 | 1 |
| 2030-12-31 | $0.32 | $0.32 | $0.32 | 1 |
Frequently Asked Questions
What is the analyst consensus for SIBN?
The consensus among 7 analysts covering SI-BONE, Inc. (SIBN) is Buy with an average price target of $25.25.
What is the highest price target for SIBN?
The highest price target for SIBN is $32.00, set by David Saxon at Needham on 2023-07-12.
What is the lowest price target for SIBN?
The lowest price target for SIBN is $18.00, set by Samuel Brodovsky at Truist Financial on 2024-08-06.
How many analysts cover SIBN?
7 analysts have issued ratings for SI-BONE, Inc. in the past 12 months.
Is SIBN a buy or sell right now?
Based on 7 analyst ratings, SIBN has a consensus rating of Buy (2.00/5) with a +69.2% upside to the consensus target of $25.25.
What are the earnings estimates for SIBN?
Analysts estimate SIBN will report EPS of $-0.16 for the period ending 2026-06-30, with revenue estimated at $56M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.